Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: A proteomic approach
Author:
Funder
Australian and New Zealand Head and Neck Cancer Society
Publisher
Elsevier BV
Reference27 articles.
1. Head and neck cancer immunotherapy: molecular biological aspects of preclinical and clinical research;Chakraborty;Cancers,2023
2. Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case;Farhat;Discov Oncol,2022
3. A randomized phase 2 study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma;Mahmood;Int J Radiat Oncol Biol Phys,2021
4. Roles of the immune system in cancer: from tumor initiation to metastatic progression;Gonzalez;Genes Dev,2018
5. PD-1/PD-L1 pathway: current researches in cancer;Han;Am J Cancer Res,2020
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Letter to the editor, “Inhibition of anti-tumour reactivity of immune cells in the salivary gland cancer: A proteomic approach.”;Oral Oncology Reports;2024-09
2. Protein–protein-interaction assay coupled with proteome profiler and immune activation flow cytometry assay validate immune activation in 3D oral cancer-immune co-culture model;Journal of Proteins and Proteomics;2024-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3